Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
13,010
-300 (-2.25%)
At close: Jan 30, 2026
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 62.61B KRW in the quarter ending September 30, 2025, with 12.21% growth. This brings the company's revenue in the last twelve months to 231.90B, up 7.64% year-over-year. In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B with 10.42% growth.
Revenue (ttm)
231.90B
Revenue Growth
+7.64%
P/S Ratio
2.94
Revenue / Employee
286.65M
Employees
809
Market Cap
682.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.06T |
| Chong Kun Dang Pharmaceutical | 1.68T |
| Dong-A Socio Holdings | 1.40T |
| Boryung | 1.03T |
| DongKook Pharmaceutical | 894.93B |
| Huons Global | 825.44B |
| Dong-A ST | 770.63B |
| JW Pharmaceutical | 764.21B |